Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Lions Capital acquires Pender NDI Life Sciences Fund

Fasken
Reading Time 1 minute read Subscribe
Client

Lions Capital

On October 5, 2007, Lions Capital Corp. acquired the fund management agreement for Pender NDI Life Sciences Fund ("Pender NDI") from Pender Fund Capital Management Ltd., a wholly owned subsidiary of Pender Financial Group Corp. Lions Capital is the fund manager of BC Advantage Funds ("Advantage") and Lions Liquidity Investment Fund I Limited Partnership and manages more than $57 million of venture capital. Lions Capital also provides financing, merger and acquisition, and financial advisory services to life science and technology companies. Lions Capital was advised in this acquisition by a team from Fasken Martineau that included Gary Ott, Iain Mant, Prentice Durbin, Andrey Schmidt and Andrew Jackson.

    Subscribe

    Receive email updates from our team

    Subscribe